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1. Introduction 
In recent years Baker and Erickson have achieved 
considerable success in producing potent active-site- 
directed irreversible inhibtors of trypsin [ 1, 21. These 
compounds are derivatives of (phenoxyalkoxy)benz- 
amidine and they undergo covalent bonding to the 
enzym: with the help of a terminal sulfonylfluoride 
group. One of the strongest inhibitors was found in 
p-[m(m-fluorosulfonylphenylureido)phenoxyethoxy] 
benzamidine [ 21: 
‘NHCONH-C,H4-SO,F-m 
This communication is a more detailed account of the 
kinetic parameters of the interaction of the inhibitor 
with trypsin and, in addition, describes the effect of 
the compound on pancreatic kallikrein, thrombin, 
and plasmin. 
2. Experimental procedure 
2.1. Materials 
p- [m(m-Fluorosulfonylphenylureido)phenoxy- 
ethoxy] benzamidine benzene sulfonate (FPPB) was 
a product of Cycle Chemical. Bovine trypsin (2 X 
crystallized; salt free), iVa-benzoyl-L-arginine ethyl 
ester-HCl (BAEE) and p-tosyl-Larginine methyl 
ester-HCl (TAME) were obtained from Schwarz-Mann. 
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Lyophilized hog pancreatic kallikrein was kindly sup- 
plied by Farbenfabriken Bayer AG. The material was 
free of trypsin and contained 125 KU/mg (KU = inhi- 
bitor units according to Frey et al. [3] ). Bovine 
thrombin (topical) was purchased from Parke, Davis 
and Co. Human plasmin in 50% glycerol solution was 
obtained from AB KABI. 
2.2. Methods 
The enzymes were incubated for various periods of 
time with the inhibitor and afterwards the amount of 
residual enzymatic activity was determined in rate 
assays. The degree of dilution of the inhibition mix- 
tures following incubation and the concentration of 
the substrates in the assays were chosen such that they 
eliminated any continuing reversible or irreversible 
blocking effect of FPPB. The composition of the in- 
hibition mixtures was as follows: for trypsin, 0.4 ml 
of 0.05 M Tris-HCl buffer pH 8.1 contained 0.5 - 
5.7 pg of the enzyme, 0.75 - 12 X 10e6 M FPPB, 
0.02 M CaCl, and 2.5% v/v dimethylsulfoxide 
(DMSO). The larger amounts of trypsin were employed 
with the higher inhibitor concentrations to make pos- 
sible a greater dilution before the assay step and still 
to be able to measure trypsin accurately. For kallikrein, 
0.8 ml of 0.01 M Tris-HCl buffer pH 8.1 included 1 KU 
of the enzyme, 2 - 8 X 10m6 M FPPB and 2.5% v/v 
DMSO. For thrombin, 200 NIH units of the enzyme 
and 1 - 6.4 X 10e4 M FPPB were incorporated into 
0.5 ml of 0.02 M phosphate buffer pH 8.0 containing 
4% v/v DMSO. For plasmin, 0.6 ml of 0.05 M Tris-HCl 
buffer pH 8.1 contained 2 units (casein units accord- 
ing to Sgouris [4]) of the enzyme, 3.3 -- 13 X lo5 M 
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Fig.i. Loss of trypsin activity upon incubation of the enzyme 
with various concentrations of FPPB at 37” and pH 8.1. 
FPPB, 3.39% v/v DMSO and 17% v/v glycerol. 
BAEE was employed as substrate to measure the ac- 
tivities of trypsin, plasmin, and kallikrein. With the 
first two enzymes Schwert and Take&a’s assay meth- 
od [5] and a BAEE concentration of 1 X IO” M were 
chosen, while with kallikrein a modified Hestrin meth- 
od [6] and a substrate concentration of 1 X lo2 M 
were used. Thrombin activity was determined accord- 
ing to the procedure of Siegelman et al. [7] by mea- 
suring the amount of methanol released during the 
hydrolysis of TAME. 
3. Results and discussion 
Fig. 1 shows that in the presencesof an excess of 
FPPB the inhibition of trypsin followed apparent first 
order kinetics. From such graphs the pseudo first order 
rate constants were determined for the inhibitor con- 
centrations chosen, and the values of several experi- 
ments were averaged. A double reciprocal plot of the 
mean pseudo first order constants thus obtained 
against inhibitor concentration resulted in a straight 
line which intersected the y-axis above the point of 
origin (fig.2) and allowed the graphic determination 
of the limiting rate constant of inactivation at high 
inhibitor concentrations, i.e., of k2 [8]. Occurrence of 
a positive intercept on the ordinate proved the forma- 
tion of a reversible enzyme-inhibitor complex before 
the enzyme was irreversibly inhibited, and the reac- 
tion sequence can therefore be written as 
Table 1 
Kinetic parameters for the inhibition of trypsin, pancreatic 
kallikrein, thrombin and plasmin by p-[m(m-fluorosulfonyl- 
phenylureido)phenoxyethoxy] benzamidine (FPPB). 
Enzyme /c~ (min-I) +lim * Ki (M) 
Trypsin 3.70 11 set 8.9 X 1O-6 
Kallikrein 0.0425 16 min 4.3 x 10‘6 
Thrombin 0.0122 57 min 7.5 x 10-a 
Plasniin 0.0014 478 min 2.5 x lo+ 
* Half-life of the enzyme at the limiting rate of inactivation 
k,. 
Et1 
As (I) was chosen considerably greater than (E) it was 
possible to calculate the inhibition constant Kj from 
the formula 
K, -=L+lxL 1 
k app k2 k2 0) 
4r 
PI 
3- 
Fig.2. Plots of l/k app against l/(l) for the inactivation of 
trypsin by FPPB. The limiting rate of inactivation determined 
from the positive intercept on the ordinate is identical with 
k,. 
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Plots of l/k,,, against 1 /(I) were constructed also for 
pancreatic kallikrein, thrombin and plasmin and, as 
with trypsin, they showed a positive intercept on the 
ordinate. The kinetic data for all the enzymes are 
summarized in table 1. It is evident that FPPB is in- 
deed a powerful inhibitor of trypsin. The k, value of 
3.70 min-l (pH 8.1,37”) compares favorably with a 
value of 0.16 minl as reported for TLCK with 
/3-trypsin (pH 7.0, 25”) [9]. Interestingly, pancreatic 
kallikrein was also readily inhibited by FPPB though 
TLCK is without influence on this enzyme [lo]. The 
rate of inactivation of thrombin was less than one 
third that of kallikrein while plasmin was still consi- 
derably less susceptible to inhibition. It should be 
pointed,out that there was no correlation between 
Ki and k2 values for different enzymes. Thus, the 
inhibitor had a much greater affinity for plasmin than 
for thrombin yet despite this, k2 was about 9 times 
greater with thrombin than with plasmin. 
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